BackCreative Medical Technology Holdings Overview
Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings Return on Equity

Latest ROE for Creative Medical Technology Holdings: -94.31% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-94.31%

Return on Equity

-94.31%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Creative Medical Technology Holdings (CELZ) FAQ

The latest ROE for CELZ is -94.31%. That is below the sector sector average of -4.03%. Investors often review this figure alongside Creative Medical Technology Holdings's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, CELZ currently prints -94.31% for ROE, while the sector average sits near -4.03%. That is roughly 2243.1% below the sector mean. Large gaps often invite a closer look at Creative Medical Technology Holdings's growth, margins, and balance sheet.

Return on Equity shows how effectively Creative Medical Technology Holdings converts resources into returns. At -94.31%, CELZ may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CELZ's ROE (-94.31%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.